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Abstract
Youth living with HIV are often inconsistent with their HIV medication adherence. HIV
medication adherence is critical for the treatment of HIV and prevention for future transmission.
Understanding associated behaviors that may impact adherence for individuals living with HIV
is necessary for their continued care. The current study aimed to more fully identify the
influences engaging in risk behaviors, health promoting behaviors and experiencing depressive
symptoms have on HIV medication adherence in adolescents and young adults with HIV.
Participants were 92 adolescents and young adults with HIV living in the mid-south region of the
United States. Individuals completed surveys about demographics, psychosocial behaviors,
depressive symptoms and antiretroviral therapy (ART) medication adherence during a clinic
visit. Path analyses were conducted to measure the model fit of the Reflective-Impulsive theory
on ART adherence. Results did not support any significant path coefficients, variance explained,
or mediation effects. These findings suggest limited insight into health and risk factors related to
ART adherence in youth living with HIV, but may offer some suggestions for future research.
Further study is warranted to understand the relationship among these factors in order to improve
ART adherence and health outcomes.

Key words: HIV, Adherence, Youth, Health behaviors, Risk Behaviors, Path analysis

iii

Manuscript Word Count: 8,448

Table of Contents
Table Index ..................................................................................................................................... v
Figure Index ................................................................................................................................... vi
Introduction ..................................................................................................................................... 1
Theoretical Framework ............................................................................................................... 2
Study Purpose and Models.......................................................................................................... 5
Method ............................................................................................................................................ 8
Participants and Recruitment ...................................................................................................... 8
Study Procedures ........................................................................................................................ 8
Measures ..................................................................................................................................... 8
Statisical Analyses .................................................................................................................... 11
Results ........................................................................................................................................... 12
Participants Characteristics ....................................................................................................... 12
Path Model Estimation .............................................................................................................. 17
Summary ................................................................................................................................... 30
Discussion ..................................................................................................................................... 30
Insufficient model ..................................................................................................................... 31
Inadequate data and statisitics ................................................................................................... 32
Secondary findings.................................................................................................................... 33
Strengths and limitations........................................................................................................... 34
Future Directions ...................................................................................................................... 35
Clinical implications ................................................................................................................. 37
Conclusion ................................................................................................................................ 38
References:.................................................................................................................................... 40

iv

Table Index
Table 1 .......................................................................................................................................... 14
Table 2 .......................................................................................................................................... 16
Table 3 .......................................................................................................................................... 20
Table 4 .......................................................................................................................................... 21
Table 5 .......................................................................................................................................... 24
Table 6 .......................................................................................................................................... 25
Table 7 .......................................................................................................................................... 28
Table 8 .......................................................................................................................................... 29

v

Figure Index
Figure 1 ........................................................................................................................................... 6
Figure 2 ........................................................................................................................................... 6
Figure 3 ........................................................................................................................................... 7
Figure 4 ......................................................................................................................................... 20
Figure 5 ......................................................................................................................................... 23
Figure 6 ......................................................................................................................................... 27

vi

INTRODUCTION
The United States Center for Disease Control and Prevention estimates that 1.2 million
Americans are living with HIV with approximately 50,000 new infections annually1. Youth
living with HIV aged 13-24 in the United States have been identified as a special group that
often struggles with both antiretroviral therapy (ART) adherence and increased engagement in
risk behaviors, both of which are linked with lower life expectancy and HIV transmission.2-7
Less than 1 out of 5 youth living with HIV currently adhere to ART and have a suppressed viral
load, the lowest rate of any age group.1 To complicate this problem, the number of youth living
with HIV has been steadily growing in number and currently account for over 20% of
individuals with new infections.1 The seriousness of this problem is reflected in the National
HIV/AIDS Strategy for the United States through 2020, which has focused efforts on funding
community-based organizations that provide prevention programs to reduce sexually transmitted
infections (STIs), substance use and mental health issues and increasing health promoting
behaviors.5 Efforts to identify areas to intervene and increase ART adherence are a critical
component to furthering this strategy.
While many research studies have identified factors independently related to ART
adherence, no study has put forth a model integrating risk behaviors, depressive symptoms and
health promotion behaviors as they relate to an individual’s ART adherence. 3,4,8-10 Health
promotion behaviors, such as physical activity and nutrition, are relatively new additions to the
interventions focused on increasing ART adherence. 11,12 Furthermore, continued efforts to
identify health behaviors, and their relation to ART adherence, falls in line with the CDC and
National HIV/AIDS Strategy goals of increasing ART adherence in youth while preventing the
spread of HIV to currently uninfected individuals. Given this troubling lack of ART adherence
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and its consequences for youth living with HIV as well as HIV prevention efforts, the research
reported here tested predictive models of adherence that included the new health promotion
factors, as well as already established constructs, in an effort to better understand their
interrelationship and identify areas of potential intervention.
Theoretical Framework
Informed by decades of dual-process theories in social psychology concerning decision
making and behavior, the Reflective-Impulsive Model (RIM) explained information processing
by theorizing two systems, reflective and impulsive . 13,14 The model outlined how behavior can
be instigated by both a thoughtful and deliberate choice (the reflective system) and by a more
automatic and want-based reflex (the impulsive system). For example, “How can it be that one
decides to eat a healthy lunch but still reaches out for the sweet muffin?” 13 In this example, the
reflective system is illustrated by a thoughtful and deliberate choice to eat a healthy lunch, while
eating the sweet muffin illustrates the more automatic, and want-based, impulsive system. The
RIM model incorporates both the reflective and impulsive systems in an integrated dual-process
model that encompasses components of behavior, knowledge and affect to explain the actions an
individual takes.13
The Reflective-Impulsive Model (RIM) is well suited to help explain the relationship
between health-related behaviors and affect in adolescents and young adults, including their
medication adherence.13,14 The impulsive system is always active and directs behavior through
“what feels good/is habitual,” seeking pleasure and avoiding pain, and is less reasoned and
conscious (e.g., “I have unprotected sex when I’m living in the moment”). Conversely, the
reflective system is not automatic and includes judgments, evaluations of pros and cons, and
intentions.15 The reflective system is characterized by reasoned, conscious and intentional plans

2

and decisions that activate behaviors (e.g., “I’m going to take my medication to improve my
health”). Products from the two systems interacting help determine an individual's behavior.
According to work by Hofman, Friese and Strack16 the reflective system has less
influence on decision-making when an individual is experiencing limiting factors like high
cognitive load, alcohol consumption, lower capacity for self-control, low working memory,
when behavior is habitual, and when affect is reactive. Previous research has used the RIM to
conceptualize the relationships and impact of these limiting factors on predicting health-related
behaviors. For example, one set of studies used measures of impulsivity, controlled behavior
and cognitive capacity to successfully predict three distinct behavioral situations: 1.) Choice of
fruit versus chocolate, 2.) potato chip consumption and 3.) beer drinking.17 Results supported
impulsivity and controlled behavior as independent and unique predictors of health behaviors
when cognitive capacity was within normal functioning. However, when cognitive capacity was
lowered (i.e., watching highly emotional movie clips of violence and aggression) impulsivity
was found to have more influence in predicting behavior.17 In applying the RIM framework to
the current research, we propose that ART adherence in an individual living with HIV is, at
least in part, determined by the interaction between affect and impulsive and reflective health
behaviors.
Health-risk and impulsive behaviors such as substance use and unprotected sex are often
framed as “barriers” to a healthy lifestyle and are inconsistent with ART adherence. Known
barriers to ART adherence include engaging in risk behaviors such as risky sexual behaviors
(e.g., low or no condom use).8,9,18-20 For instance, one survey of over 350 youth in the United
States found that 42% of their youth sample reported engaging in sexual risk behaviors, and of
that 42% over half endorsed also experiencing inconsistent ART adherence. 19 Substance use,
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and substance use-related factors, have also been found to be significant barriers to ART
adherence for adolescents.10,18 Youth diagnosed with HIV who report cannabis abuse have been
found to have poorer ART adherence for multiple reasons such as forgetting to take their ART,
and a lack of motivation to take ART after cannabis use. 21 Moreover, higher rates of cannabis
use and depressive symptoms were significant predictors of non-adherence in youth with HIV.3
While the research on the RIM has measured the impulsivity and reflective components more
in-depth, including measurement of affect and its role within the model remains largely
unexplored.
Health promoting behaviors such as engaging in physical activity and consuming
nutritional diet are more likely to be products of the reflective system in that they are conscious
and reasoned decisions. The limited existing research in this area has shown that engaging in
physical activity and consuming nutrition are associated with reducing negative affect and
increasing ART adherence.11,12 The integration of physical activity and nutritional diets into
behavioral intervention models focused on improving ART adherence for adolescents has
shown promising results.22 Specific forms of physical activity including walking, swimming
and rollerblading were reported and perceived as helpful in self-care by individuals with HIV,
with and without a depressive symptoms.23
In general, the RIM focuses on reflective and impulse behaviors as they relate to health
choices such as medication adherence but little research on this framework has attempted to
integrate affect into the research. The inclusion of affect is particularly important because
individuals living with HIV are significantly impacted by depressive and anxiety symptoms.
Youth living with HIV often struggle with learning about their HIV diagnosis and depressive
symptoms concurrently and as a result have negative outcomes related to their psychosocial

4

functioning and health.3,24,25 Depressive symptoms along with anxiety symptoms significantly
predict lower ART adherence, accounting for over 20% of the variance in individuals’ ART
adherence.3
The purpose of the current study was to conduct a set of secondary analyses testing theorybased predictive models of adherence that include established predictors, the new health promotion
factors, as well as affective factors, in an effort to better understand their interrelationship and
identify areas of potential intervention for youth living with HIV. Our study focused specifically on
ART adherence outcomes because of the critical impact medication has on individuals’ physical
and mental health outcomes. Given the RIM literature, we hypothesized that antecedent
components such as nutrition, physical activity, unprotected sex, substance use and depressive
symptoms would both directly and indirectly impact ART adherence. Our conceptual model,
adapted from previous work by Hofmann, Friese and Wiers 26, provides a framework for examining
available health behavior variables and additional affect hypotheses. See Figures 1 -3 below.
Study Purpose and Models
The purpose of this study was to examine three alternative models of the relationships
between risk behaviors, health promotion behaviors, depressive symptoms and ART adherence
indicators. The three alternative models and their comparison can help better understand
variable relationships and potential causal effects impacting ART adherence in youth.
Model 1 (shown in Figure 1) examined 1) direct relationships from risk behaviors and
health promotion behaviors to depressive symptoms and from depressive symptoms to ART
adherence, and 2) indirect relationships from risk behaviors and health promotion behaviors to
ART adherence, both through the mediation of depressive symptoms.
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Figure 1.
Model 2 (shown in Figure 2) also examined the same relationships as specified in
Model 1; In addition, based on empirical evidence, direct relationships from risk behaviors and
health promotion behaviors to ART adherence will be added and tested.
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Figure 2.

Model 3 (shown in Figure 3) examined 1) direct relationships from depressive symptoms to risk
behaviors and health promotion behaviors, and from both risk behaviors and health promotion
behaviors to ART adherence; 2) As such, the model also tested the direct relationships from
depressive symptoms to ART adherence, and the mediation of risk behaviors and health
promotion behaviors.
6

Risk
Behaviors
ART
Adherence

Depressive
Symptoms

Health
Promotion
Behaviors

Figure 3.

7

METHODS
Participants and recruitment
The data were collected from youth (ages 16-24) living with HIV in care at a hospital
clinic in the Mid-south region of the United States. Recruitment was for an exploratory study on
body image.27 All participants consented themselves, or had parental consent if under 18 years
old. Participants were eligible for approach if they were aware of their diagnosis, their primary
language was English, they were between the ages of 16-24, and were not pregnant. Additional
exclusion criteria included diagnosis of an intellectual disability or a significant motor or sensory
impairment, or known acute psychiatric illness, including active suicidal ideation, homicidal
ideation or psychosis. In addition, participants needed to have been prescribed an ART regimen.
No other limits were set in terms of sexual orientation, education, or other demographic
information in order to increase the generalizability of the results. A total of 92 participants fit
the inclusion criteria and completed the questionnaires for the proposed study.
Study procedures
Youth with vertically and behaviorally acquired HIV were approached for study
participation during their routine infectious disease clinical visit. After obtaining informed
consent, participants completed an Audio Computer Assisted Self-Interview (ACASI) in a
private clinic room. Additional clinical information was abstracted from the participant’s medical
record by study staff. The clinic’s Institutional Review Board (IRB) approved the current study
with agreement from governing University.
Measures
Demographic characteristics. Each participant was asked various demographic questions,
including their gender, marital status, education level, employment status and income level.
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Social and environmental questions were also asked about utilization of public assistance
programs (e.g., food stamps). Additional clinical values such as HIV viral load and CD4 cell
count/% were obtained in a medical record review and are presented in Table 1.
Risk Behaviors and Health Promotion Behaviors. Previous risk behaviors were assessed
using the Youth Risk Behavior Surveillance System (YRBSS) 28, a survey developed by the
Centers for Disease Control and Prevention (CDC) to gather educational and health information
for government agencies. The YRBSS monitors six categories of health-risk behaviors among
youth and young adults including: behaviors that contribute to unintentional injuries and
violence; tobacco use; alcohol and other drug use; sexual behaviors related to unintentional
pregnancy and sexually transmitted diseases including HIV; unhealthy dietary behaviors; and
physical inactivity. The individual items vary on type and number of responses; for example,
“Did you drink alcohol or use drugs before you had sexual intercourse the last time? A. I have
never had sexual intercourse, B. Yes, or C. No” while another item reads, “During the past 7
days, how many times did you eat other vegetables? (Do not count green salad, potatoes, or
carrots.) A. I did not eat other vegetables during the past 7 days, B. 1 to 3 times during the past 7
days, C. 4 to 6 times during the past 7 days, D. 1 time per day, E. 2 times per day, F. 3 times per
day, or G. 4 or more times per day” For the purposes of the current study, questions pertaining to
risk behaviors were selected (i.e., Number of sexual partners in past 3 months; condom use at
last sexual encounter; alcohol or substance use during last sexual encounter) as well as the health
promotion behaviors (i.e., Physical activity in last 7 days; Vegetables in last 7 days). Previous
reliability tests demonstrated Cohen’s kappas ranging from 23.6% to 90.5%, with a mean of
60.7% and a median 60.0%, indicating moderate reliability.29,30
Depressive symptoms. Symptoms of depression were assessed by the Center for
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Epidemiological Studies Depression Scale-10 (CESD-10)31. The CESD-10 is a short form that
consists of ten items that asks the patient to rate symptoms (e.g., “I felt lonely”; “I could not “get
going”) over the last week. Each item is scored 0 to 3 [0=Rarely or none of the time (less than 1
day); 1=Some or a little of the time (1-2 days); 2=Occasionally or a moderate amount of time (34 days); 3=Most or all of the time (5-7 days)]. Total scores range from 0-30, and higher scores
indicated higher depressive symptoms. Cronbach’s alpha for the CESD-10 has been measured as
α=.72 in the general population32 and α=.88 in an HIV-specific sample33.
ART Adherence. Three measures of ART adherence were used. The first measure of
ART adherence was a self-reported estimate of adherence using the Visual Analog Scale (VAS)
which remains widely used with individuals living with HIV.34-36 The VAS for ART adherence
appears as a continuous scale representing the percent of ART taken relative to that which has
been prescribed, for a given HIV medication, during a month long period. Patients are presented
with a line anchored at 0% and 100% and asked to assess their own ART adherence. The second
indicator was a single item asking “When was the last time you missed a dose of your HIV
medication?” with response options of: “Today, Yesterday, Earlier this week, Last week, Less
than a month ago, More than a month ago, and Never.” The third measure was the adherence
rates provided by the clinic’s pharmacy pill count (PPC). The PPC is a hybrid adherence measure
using pill count and pharmacy refill, both of which are usually classified as “objective measures”
and deemed acceptable and valid measures of adherence in the general population and in HIVspecific samples.37,38 It is clinic policy for patients to bring their HIV medications to all
appointments in the clinic. The patient is instructed to drop-off their ART bottles or pillboxes at
the pharmacy which is housed within the clinic building. During their appointment, the
pharmacists or pharmacy technicians count the pills left and enter the values into the patient’s
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medical chart. This number is compared to last refill of the HIV medication, giving the clinic a
number and percentage of pills taken compared to the amount prescribed that should remain.
Statistical Analyses
All descriptive and correlational statistics were conducted using IBM SPSS Statistics for
Macs, Version 24.0 (IBM Corp., 2017, Armonk, NY). First, descriptive analyses were conducted
to describe participant characteristics. Second, zero-order correlations were performed to
examine relationships between all model variables. Researchers planned to combine the three
adherence indicators to measure adherence as a latent variable. However, very low factor
loadings demonstrated no evidence to support their combination as measuring one overarching
construct. Given the statistical support, the three adherence outcome variables were kept
independent and ran as separate path analyses. This changed the proposed three models to a total
of nine models. Third, path analyses were conducted using the structural equation modeling
(SEM) software package Mplus, Version 8.0, to jointly model the direct and indirect
relationships in the proposed models that examine relationships between the health and risk
behaviors, depressive symptoms, and the three adherence outcome variables. See figures 4 – 6
for conceptual illustrations.
Since all available variables for analysis were observed rather than latent, and the goal of
this analysis was to use the general SEM framework to test the fit of nine path analysis models.
Maximum likelihood (ML) was used for model estimation. Model fit indices were only used in
three of the models (i.e., models 1a, 1b, and 1c) of the current study because the other six models
(i.e., models 2a-c and 3a-c) proposed prespecified, fully saturated path analysis models. This is a
result of utilizing RIM theory and the limited observed variables in the available and pre-existing
data set. For a fully saturated model, the global model fit is perfect (i.e., 0.00 or 1.00) and does
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not inform us on how well the current study data fits the pre-specified measurement model.
Standardized beta (β) regression coefficients are reported for each direct and indirect effect.
The “gold” standard recommends that the smallest acceptable sample size in studies
using structural equation modeling is approximately 200.39 However, because the proposed study
is a secondary analysis, the sample size is predetermined and falls below 200. Given this, a
second method of determining sample size was based on Kline’s (2010) sample size
recommendations that uses the ratio of cases (n) to the number of parameters that require
statistical estimates (q); (n:q), with an ideal ratio being 20:1 and less ideal being 10:1 and 5:1
being unacceptable. In the proposed study, there are 92 cases (n) and ten parameters (q), (~
10:1). As such, this study has an acceptable ratio of cases to parameters, which supports the use
of SEM as an appropriate analysis.
This study examined the relationships between risk behaviors, health promotion
behaviors, depressive symptoms and ART adherence. It investigated the impact of risk behaviors
and health promotion behaviors on ART adherence, as well as the impact of depressive
symptoms on ART adherence for youth living with HIV. The first two models evaluated whether
depression mediates the relationship between both risk behaviors and health promotions and
ART adherence. As a possible alternative, the final model evaluated whether risk behaviors
and/or health promotion behaviors mediate the relationship between depressive symptoms and
ART adherence.
RESULTS
Participant characteristics
The mean age of the sample was 20.9 years (standard deviation = 1.93). The majority of
participants identified as male (76.3%), Black (95.9%), gay (46.4%), men who have sex with
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men (66.0%), single (94.8%), pursuing education (51.5%) and employed (54.6). Table 1
provides full participant demographic data.
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Table 1.
Sample Characteristics
Characteristic
Age
CD4 Absolute
CD4 Percentage
HIV Viral Load (copies/ml)

Mean
20.8
636.25
30.40
11724.05

Gender
Male
Female
Race
Black
White
Transmission Route
Vertical
Horizontal
Sexual Orientation
Straight
Gay
Lesbian
Bisexual
Other
Education
12th grade or less
High School Diploma/GED
Some College
College or more
Student status
Not currently enrolled
Full/part-time
Employment status
Full-time
Part-time
Not employed

14

SD
1.96
327.50
10.78
35075.53

n

%

71
21

77.2
22.8

88
4

95.7
4.3

14
78

15.2
84.8

28
43
1
17
3

30.4
46.7
1.1
18.5
3.3

17
36
27
12

18.5
39.2
29.3
13

45
47

48.9
51.1

32
20
40

34.8
21.7
43.5

Prior to conducting model estimation, we prepared the data in three steps. First, we
checked for missing values. It was found that our data had limited missing values. Specifically,
one case was missing values on the Visual Analog Scale, Substance use during last sexual
encounter, and the Health Risk Behavior mean variables, which reduced the n from 92 to 91 on
those three variables. Also, the pharmacy pill count only had data available for 71 of the
participants. Second, in order to assess univariate normality, we computed skewness and
kurtosis, and it was found that all interval and ratio variables in our data were statistically nonsignificant. Due to the data including two binary items (Condom use during last sexual
encounter; Alcohol or substance use during last sexual encounter), the assumptions of
multivariate normality cannot be met. Third, correlations between each of our variables were
analyzed. Table 2 presents item means, scale means, and standard deviations for all variables of
interest, including the ART adherence indicators [1.Visual Analog Scale (VAS) self-report, 2.
Time since last missed dose self-report, 3. Pharmacy pill count (PPC)], CESD-10 scores, health
promoting behaviors (i.e., Physical activity in last 7 days; Vegetables in last 7 days), and the risk
behaviors (i.e., Number of sexual partners in past 3 months; condom use at last sexual encounter;
alcohol or substance use during last sexual encounter). Zero-order correlations were also
examined between the constructs of interest and are presented in Table 2.
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Table 2.
Descriptives and correlations of predictor, mediation, and outcome variables
1
2
3
4
1. Visual Analog Scale (VAS)
2. Time since last missed dose
3. Pharmacy Pill Count (PPC)
.50**
4. CESD-10 score
-.10
5. Physical Activity in last 7
days
.04
6. Vegetables in the last 7 days
.13
7. Health Promotion Behaviors
Means
.09
8. Number of sexual partners
in the past 3 months
-.06
9. No condom use last sexual
encounter
.07
10. Alcohol or substance use
during last sexual encounter
.01
11. Health Risk Behavior
Mean
-.04
N
91
Mean
82.3
Range
0-100
SD
25.9
Note. *p < at 0.05 level. **p at 0.01 level.

5

6

7

8

9

.43**
.47**
-.15

.06

.07
.08

.11
.21

-.08
-.18

.40**

.09

.18

-.14

.90**

.76**

-.19

-.08

-.09

.28*

.11

.21*

-.07

.07

.14

-.12

-.07

-.11

.05

-.16

.17

.12

.00

-.06

-.03

.19

-.05

-.25*
92
4.9
0-7
1.9

-.07
71
89.8
0-100
15.3

-.03
92
9.4
0-24
6.0

.00
92
3.15
0-7
2.5

.07
92
1.88
0-7
1.9

.15
92
2.5
0-7
1.8

.95**
92
1.75
0-99
1.8

.26*
92
0.20
0-1
0.4
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.41*
91
0.29
0-1
0.5

11

91
1.8
0-99
0.7

Path Model Estimation
Model construction and evaluation were completed using structural equation modeling
(SEM). Data were analyzed using Mplus 7.4 (Muthen & Muthen, 2015) statistical software.
When possible, model fit was tested using Chi-square statistics and common fit indices, such as
Comparative Fit Index (CFI), Tucker Lewis Index (TLI), Standardized Root Mean Square
Residual (SRMR), and Root Mean Square Error of Approximation (RMSEA). Good model fit
indices were specified by a CFI and TLI of at least .95, a RMSEA of <. 06, a SRMR of <. 08,
and non-significant Chi-square statistic (Weston, Gore, Chan, & Catalano, 2008). Additionally,
parameter estimates were estimated using 5000 bootstrap samples. The bootstrapping method has
been suggested in mediation models to better assess indirect effects with bias-corrected 95%
confidence intervals (Hayes, 2009).
The a priori models were specified and estimated first to assess for multivariate outliers.
No participants were identified as multivariate outliers based on Cook’s distance and
Mahalanobis distance. After the models were estimated, path coefficients were evaluated for
statistical significance.
Several path models were structured to evaluate the study’s hypotheses. A priori models
were specified and included model 1 (Figure 4): health promotion behaviors, health risk
behaviors variables as indirect predictors, depressive symptoms as a mediator and the three ART
adherence indicators (i.e., Visual Analog Scale [monthly self-report], last missed dosage and
pharmacy pill count) as the endogenous measure in the three separated models; model 2 (Figure
5): health promotion behaviors, health risk behaviors variables as direct predictors, depressive
symptoms as a mediator and ART adherence indicators (i.e., Visual Analog Scale [monthly selfreport], last missed dosage and pharmacy pill count) as outcomes; model 3 (Figure 6): depressive
symptoms as a predictor, health promotion behaviors (HPB) and health risk behaviors as
17

mediators and adherence indicators as outcomes.
All model parameters are presented in Tables 3 through 8. In models 1a-c, health
promotion behaviors, health risk behaviors variables are the exogenous variables, depressive
symptoms is a mediator and an endogenous/exogenous variable, and the three measures of ART
adherence indicators, including Visual Analog Scale [monthly self-report], last missed dosage
and pharmacy pill count are each used as the endogenous variable in three separated models. The
relationships tested were direct: 1.) from impulsive risk behaviors to depressive symptoms, 2.)
from HPBs to depressive symptoms, and 3.) from depressive symptoms to ART adherence. The
indirect and mediation relationships tested were: 1.) role of depressive symptoms between risk
behaviors and 2.) ART adherence as well as 3.) between HPBs and ART adherence. The indirect
relationships tested were: 1.) from risk behaviors to ART adherence and 2.) from HPBs to ART
adherence. In comparison to models 2a-c and 3a-c that will be discussed next, only model 1a-c
posits the reflective and impulsive behaviors best explain ART adherence indirectly (through
affect) as opposed to directly explaining the influence of impulsive and reflective behaviors on
ART adherence.
Model 1a was not supported by the data. Although data demonstrated a perfect model fit
indicator (RMSEA = .00), this value should be attributed to X 2 being less than df and a low
sample size, both of which are known to set RMSEA at zero.40 No other fit indices were
available. There were no statistically significant path coefficients between risk behaviors, health
promotion behaviors, depressive symptoms, and monthly adherence. Depressive symptoms
explained 1% (R2 = .01), and risk and health behaviors explained < 1% (R2 = <.01) of the
variance in predicting monthly adherence. Model 1b was not supported by the data. Although
data demonstrated an acceptable model fit indicator (RMSEA = .07), it is more likely that this

18

was due to the minimal difference between X 2 and df.40 No other fit indices were available.
There were no statistically significant path coefficients between risk behaviors, health promotion
behaviors, depressive symptoms, and time since last missed dose. Depressive symptoms
explained 3% (R2 = .03), and risk and health behaviors explained 2% (R2 = .02) of the variance
in predicting time since last missed dose. Model 1c was not supported by the data as evidenced
by a poor model fit indicator (RMSEA = .13). No other fit indices were available. There were no
statistically significant path coefficients between risk behaviors, health promotion behaviors,
depressive symptoms, and pharmacy pill count. Depressive symptoms explained <1% (R2 = .00),
and risk and health behaviors explained 2% (R2 = .02) of the variance in predicting pharmacy pill
count.
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Figure 4.
The a priori model 1 for path analysis including all predictors, mediators, and outcomes. Note. Model 1
tested three ART adherence indictors: a. Visual Analog Scale (self-report monthly adherence), b. time
since last missed dose, c. pharmacy pill count

Table 3.
Values of Selected Fit Statisics for the full model 1a, 1b, and 1c.
Model
X2
df
X2/df
RSMEA
Model 1a.) ART Adherence
Visual Analog Scale
1.41
2
0.7
.00

CFI

SRMR

1.00

0.03

Model 1b.) ART Adherence
Time since last missed dose

3.09

2

1.5

.07

0.64

0.05

Model 1c.) ART adherence
Pharmacy Pill count

4.95

2

2.5

.13

0.00

0.07
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Table 4.
Standardized and Unstandardized Coefficients for the models 1a, 1b, and 1c.
Maximum likelihood Estimates From 5000 Bootstrap Samples
Dependent Variable
Independent
Unstandardized Standard
S.E.
P-value
R2
Variable
Est.
Est.
Model 1a.) ART Adherence
Visual Analog Scale
CESD-10
-0.42
-0.10
0.11
.35
0.00
Model 1b.) ART Adherence
Time since last missed dose

CESD-10

-0.05

-0.17

0.11

.13

0.03

Model 1c.) ART adherence
Pharmacy Pill count

CESD-10

0.16

0.06

0.44

.66

0.00

-0.49
0.57

-0.14
0.07

0.10
0.09

.13
.43

0.02

*CESD-10
Health Behaviors
Risk Behaviors
Note. * same values for models 1a, 1b, and 1c.
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In models 2a-c, health promotion behaviors and health risk behaviors variables are the
exogenous variables, depressive symptoms is a mediator, and the three measures of ART
adherence indicators: Visual Analog Scale [monthly self-report], last missed dosage and
pharmacy pill count) were individual endogenous variables for models 2a-c. The relationships
tested were direct 1.) from impulsive risk behaviors to affect/depressive symptoms, 2.) from
impulsive risk behaviors to ART adherence, 3.) from health promotion behaviors to depressive
symptoms, 4.) from health promotion behaviors to ART adherence, and 5.) from depressive
symptoms to ART adherence. The indirect and mediation relationships tested are: 1.) role of
depressive symptoms between risk behaviors and ART adherence as well as 2.) between HPBs
and ART adherence. The indirect relationships tested are: 1.) from risk behaviors to ART
adherence and 2.) from HPBs to ART adherence. The relationships tested are unique relative to
models 1a-c and 3a-c in that only model 2a-c posits the reflective and impulsive behaviors that
best explain ART adherence both directly and when mediated by depressive symptoms as
opposed to only explaining the influence of impulsive and reflective behaviors when mediated
by depressive symptoms on ART adherence.
Model 2 was just-identified, the number of free parameter equals the number of known
values; thus, fit indices were known to be limited. Model 2a was not supported by the data. As
expected, data demonstrated a perfect model fit indicator (RMSEA = .00), which is attributed to
X2 being equal to df and a low sample size.40 No other fit indices were available. There were no
statistically significant path coefficients between risk behaviors, health promotion behaviors,
depressive symptoms, and monthly adherence. Depressive symptoms, health promotion
behaviors, and risk behaviors only explained 3% (R2 = <.03) of the variance in predicting
monthly adherence. Model 2b was not supported by the data and demonstrated the default
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perfect fit (RMSEA = .00). No other fit indices were available. There were no statistically
significant path coefficients between risk behaviors, health promotion behaviors, depressive
symptoms, and time since last missed dose of ART. Depressive symptoms, health promotion
behaviors, and risk behaviors only explained 6% (R2 = <.06) of the variance in predicting the
time since last missed dose. Model 2c was not supported by the data. Results revealed the default
perfect fit (RMSEA = .00). No other fit indices were available. There were no statistically
significant path coefficients between and from risk behaviors, health promotion behaviors,
depressive symptoms, and pharmacy pill count. Depressive symptoms, health promotion
behaviors, and risk behaviors only explained 7% (R2 = <.07) of the variance in predicting
pharmacy pill count percentage.

Reflective
Health
Promotion
Behaviors

Impulsive
Risk Behaviors
Affect
Depressive
Symptoms
dDS

ART
Adherence
Indicators

dAD

Figure 5.
The a priori model 2 for path analysis including all predictors, mediators, and outcomes. Note. Model 1
tested three ART adherence indictors: a. Visual Analog Scale (self-report monthly adherence), b.Time
since last missed dose, c. pharmacy pill count
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Table 5.
Values of Selected Fit Statisics for the full model 2a, 2b, and 2c.
Model
X2
df
X2/df
RSMEA
Model 1a.) ART Adherence
Visual Analog Scale
0.00
0
0
.00

CFI

SRMR

1.00

0.00

Model 1b.) ART Adherence
Time since last missed dose

0.00

0

0

.00

1.00

0.00

Model 1c.) ART adherence
Pharmacy Pill count

0.00

0

0

.00

1.00

0.00
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Table 6.
Standardized and Unstandardized Coefficients for the models 2a, 2b, and 2c.
Maximum likelihood Estimates From 5000 Bootstrap Samples
Dependent Variable
Independent
Unstandardized Standard
S.E.
P-value
R2
Variable
Est.
Est.
Model 1a.) ART Adherence
Visual Analog Scale
CESD-10
-0.35
-0.08
0.11
.46
0.03
Health
1.31
0.09
0.12
.46
Behaviors
-3.35
-0.10
0.11
.38
Risk Behaviors
Model 1b.) ART Adherence
Time since last missed dose

Model 1c.) ART adherence
Pharmacy Pill count

CESD-10
Health
Behaviors
Risk Behaviors

CESD-10
Health
Behaviors
Risk Behaviors

-0.05
0.03
-0.44

-0.15
0.03
-0.19

0.22
1.84
-3.66

0.09
0.21
-0.18

-0.49
0.57

-0.14
0.07

0.11
0.10
0.11

.18
.74
.08

0.06

0.14
0.10
0.10

.54
.04
.07

0.07

0.36
0.85

.13
.43

0.02

*CESD-10
Health
Behaviors
Risk Behaviors
Note. * same values for models 2a, 2b and 2c.
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In models 3a-c, affect is defined as depressive symptoms and is the exogenous variable,
while risk behaviors and health promotion behaviors are the mediators, and the ART adherence
indicators (i.e., Visual Analog Scale [monthly self-report], last missed dosage and pharmacy pill
count) are the endogenous outcome variables, respectively for models a-c. The variable type is
different from models 1a-c and 2a-c in that depressive symptoms is now the exogenous variable
and the risk behaviors and health behaviors are mediating the relationship between affect
(depressive symptoms) and the ART adherence indicators.
The relationships tested are direct 1.) from depressive symptoms to risk behaviors, 2.) from
depressive symptoms to health promotion behaviors, 3.) from health promotion behaviors to
ART adherence, 4.) from risk behaviors to ART adherence. The indirect and mediation
relationships tested are: 1.) role of risk behaviors between depressive symptoms and ART
adherence as well as 2.) the role of health promotion behaviors between depressive symptoms
and ART adherence. The indirect relationships tested are: 1.) from depressive symptoms to ART
adherence through risk behaviors and 2.) from depressive symptoms to ART adherence through
health promotion behaviors. The relationships tested are unique relative to models 1a-c and 2a-c
in that only model 3a-c posits that ART adherence is best explained by measuring affect
(depressive symptoms) as mediated by reflective and impulsive behaviors.
Model 3 was also just-identified; thus, fit indices were known to be limited. Model 3a was
not supported by the data. Data demonstrated a perfect model fit indicator (RMSEA = .00),
which was attributed to X2 being equal to df and low available sample size.40 No other fit indices
were available. There were no statistically significant path coefficients between depressive
symptoms, risk behaviors, health promotion behaviors, and monthly adherence. Depressive
symptoms, health promotion behaviors, and risk behaviors only accounted for 3% (R2 = <.03) of
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the variance in predicting monthly adherence. Model 3b was not supported by the data, and
demonstrated the default perfect fit (RMSEA = .00). No other fit indices were available. There
were no statistically significant path coefficients between risk behaviors, health promotion
behaviors, depressive symptoms, and the time since last missed dose of ART. Depressive
symptoms, health promotion behaviors, and risk behaviors only accounted for 7% (R2 = <.07) of
the variance in predicting the time since last missed dose. Model 3c was not supported by the
data, and demonstrated the default perfect fit (RMSEA = .00). No other fit indices were
available. There were no statistically significant path coefficients between risk behaviors, health
promotion behaviors, depressive symptoms, and pharmacy pill count. Depressive symptoms,
health promotion behaviors, and rick behaviors only accounted for 8% (R2 = <.08) of the
variance in pharmacy pill count.

Affect
Depressive
Symptoms

Reflective
Health
Promotion
Behaviors

Impulsive
dRB

Risk Behaviors

ART
Adherence
Indicators

dHB

dAD

Figure 6.
The a priori model 3 for path analysis including all predictors, mediators, and outcomes. Note. Model 3
tested three ART adherence indictors: a. Visual Analog Scale (self-report monthly adherence), b. Time
since last missed dose, c. pharmacy pill count.
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Table 7.
Values of Selected Fit Statisics for the full model 3a, 3b, and 3c.
Model
X2
df
X2/df
RSMEA
Model 1a.) ART Adherence
Visual Analog Scale
0.98
1
0.98
.00

CFI

SRMR

0.00

0.00

Model 1b.) ART Adherence
Time since last missed dose

0.98

1

0.98

.00

0.00

0.00

Model 1c.) ART adherence
Pharmacy Pill count

0.98

1

0.98

.00

0.00

0.00
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Table 8.
Standardized and Unstandardized Coefficients for the models 3a, 3b, and 3c.
Maximum likelihood Estimates From 5000 Bootstrap Samples
Dependent Variable
Independent
Unstandardized Standard
S.E.
P-value
R2
Variable
Est.
Est.
Model 1a.) ART Adherence
Visual Analog Scale
CESD-10
1.31
0.09
0.12
.46
0.02
Health
-3.35
-0.10
0.11
.38
Behaviors
-0.35
-0.08
0.11
.46
Risk Behaviors
Model 1b.) ART Adherence
Time since last missed dose

Model 1c.) ART adherence
Pharmacy Pill count

CESD-10
Health
Behaviors
Risk Behaviors

0.03
-0.44
-0.05

0.03
-0.19
-0.15

0.10
0.11
0.11

.74
.08
.18

0.06

0.10
0.10
0.14

.04
.07
.54

0.07

CESD-10
Health
Behaviors
Risk Behaviors

1.84
-3.66
0.22

0.21
-0.18
0.09

CESD-10

-0.04

-0.14

0.09

.15

0.02

0.01

0.06

0.09

.52

0.00

*Health Behaviors

*Risk Behaviors
CESD-10
Note. * same values for models 3a, 3b, and 3c.
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Additional mediation effect analyses were planned to investigate relationships between predictor
variables, mediation variables and outcome variables. However, the poor model fit of the data
did not warrant further examination of these variable relationships.
Summary
These results do not support the idea that engagement in risk behaviors and health
promoting behaviors of the sample significantly contributed toward their ART adherence, as
measured by patient monthly self-report (VAS), patient report of time since last missed dose and
pharmacy pill count (PPC). In addition, the mediation effects remained unexamined due to the
poor data-model fit.
DISCUSSION
Given the current health challenges and consequences that youth living with HIV face,
increasing their adherence to Antiretroviral Therapy (ART) is critical and warrants closer
examination. This is particularly important given that the sample used is predominately gay,
MSM, horizontally infected youth living with HIV in the Southern U.S. region, and are a group
disproportionately impacted and underserved. In this research we tested predictive statistical
models of ART adherence with the hope of better identifying, understanding and intervening on
the behaviors, situations and related factors that influenced health consequences including
premature mortality.12,41-44 Based on previous literature, we conceptualized adherence to ART to
be the result of certain health promotion and risk behaviors as well as an individual’s
affect.13,14,17,26 In an effort to further understand the relationships among these variables we
tested three path models that used risk behaviors, health promotion behaviors, and depressive
symptoms in a sample of youth (ages 16-24) living with HIV in care at a hospital clinic to predict
three individual measures of ART adherence. These results were inconsistent with the existing
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literature on which the models were based, and did not support any of the proposed models.
Given the lack of significant findings, the following sections will exam two probable
explanations for our findings.
Insufficient model
In this research we used the Reflective-Impulsive Model (RIM) as a theoretical
framework for constructing our predictive models. However, given that we fit existing data into
the model, some components of the Reflective-Impulsive Model (RIM) framework were not
measured or assessed as suggested by model creators. The Reflective-Impulsive Model (RIM)
postulates three important domains that should be measured to best predict a health behavior, 1.)
reflective precursors and 2.) impulsive precursors, and related 3.) situational and dispositional
boundaries.26
The first domain that should be assessed is the reflective precursors (reasoned attitudes,
restraint standards, and cognitive constructs) associated with conscious goal-pursuit. Based on
the Reflective-Impulsive Model (RIM) these reflective components should be measured with
explicit self-report measures. Although the current study utilized self-reports to assess the
reflective precursors, it is probable that information gathered on nutritional diet and physical
activity did not tap into all of the cognitive processes needed to predict ART adherence. For
example, reasoned attitudes would be an important variable to include to significantly predict the
relationship between reflective variables and ART adherence.
The second domain that should be assessed is impulsive precursors such as automatic
affective reactions and automatic behavioral tendencies of approach/avoidance. In the
Reflective-Impulsive Model (RIM) a “good measure” of the impulsive system should tap into the
“hedonic or behavioral reactions” triggered in decision-making. Given the automatic and often
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unconscious nature of impulsive decisions, recommended assessment of the impulsive domain
are implicit tests including Implicit Association Test45, the Affect Misattribution Procedure46.
Given that the archival data available for this study only used explicit self-report measures to
gather information, it is possible that the measurement of the risk behaviors was insufficient and
therefore unable to significantly predict ART adherence from risk behaviors.
Lastly, the third domain that should be measured according to Reflective-Impulsive
Model (RIM) is the situational and dispositional boundaries such as coping resources and
individual differences. Fewer recommendations are made concerning the assessment of the
situation or individual differences. In the present study, we measured depressive symptoms
utilizing self-report but did not capture situational components or personality factors such as
conscientiousness. As a result, the omission of this type of information may have negatively
impacted the model’s ability to predict adherence to ART.
Given the Reflective-Impulsive Model (RIM) recommendation’s to assess all three of
these domains and to use implicit and explicit tests, the proposed model was likely deficient in
capturing all of the necessary information to accurately and significantly predict the health
behavior of ART adherence.
Inadequate Data and Statistics
The current study also had inadequate data and statistical power. The gathered data,
although available on an important, and underserved/under researched population, were
restricted by both range and type (i.e., dichotomous). Regarding restricted range, the health
promotion behavior mean was low (2.5 on a 7-point scale), which suggests that the sample was
mostly made up of individuals who do not engage in many health promoting behaviors. This
sample limitation likely inhibited the ability to test the inverse relationship between individuals
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engaging in a high amount of health promoting behaviors and their experience of depressive
symptoms. This may be characteristic of the sample collected in that older African American
youth living in the Southern United States are more likely to engage more sedentary activities
and to be overweight compared to their counterparts in other regions of the country.47,48
In addition, the data set had two dichotomous variables (alcohol and/or substance use
during last sexual encounter; condom use during last sexual encounter) contributing to the risk
behavior mean, which only allowed a range of (0-2). Beyond the restricted range issues,
dichotomous variables are historically not well suited for path analyses using ML, as they do not
meet the multivariate normality assumption and may not produce accurate regression
coeffients.49 It is likely that increasing the binary answer range to interval or ratio options would
have added a larger range, and broader variance to measure more accurate relationships between
risk behaviors, depressive symptoms, and ART adherence.
Finally, the overall small sample size of 92 participants limited the statistical power of
the analyses, which undoubtedly contributed toward the lack of significant findings. While the
sample was small it was uniquely defined by the youth to young adult age range, inclusion of
vertically and horizontally infected, as well as the multiple types of ART adherence indicators
(self-report and objective). Perhaps adding older individuals may have increased sample size but
it would take away from our specific aim of addressing this gap in adolescents and young adults.
Secondary findings
Primary results of the current study were not significant; however, some secondary
findings are useful for discussion of ART adherence and are interpreted below.
A significant positive relationship between physical activity and intake of vegetables (r = .40)
was found. This means that individuals in our sample who reported more physical activity were
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more likely to eat more vegetables, which is consistent with current literature.12,50-52 These
findings may also provide support for a collective construct of reflective behaviors (deciding to
exercise and healthy eating) being related to one another.
Regarding risk behaviors and ART outcomes, a significant negative correlation between
the risk behavior mean score and the self-reported time since last missed dose (r = -.25, p = .05)
revealed that the more risk behaviors endorsed, the more likely the individual was to have
recently missed a dose of their ART. Although not causal, this correlation is meaningful and
supports that when acted on the relationship between impulsive precursors, defined as risk
behaviors, also have influence on decision-making related to ART adherence.
Strengths and Limitations
Although our results were disappointing and inconclusive, this study was important to
conduct and had several strengths. First, we collected data from the predominately gay, MSM,
horizontally infected youth living with HIV in the Southern U.S. region, which is a
disproportionately impacted and often invisible population. Second, our study aim was aligned
with the National HIV/AIDS Strategy for the United States through 2020, which encourages
government support for research and resources for individuals living with HIV. Third, our
strength-based approach to incorporating health promotion behaviors assists in a nonpathologizing narrative consistent with patient-centered care. Lastly, the path models we put
forth aimed to map behaviors and depressive symptomsof youth living with HIV onto a
relatively new theory, which aimed to deepen the health-behavior decision making and HIV
adherence literature.
As aforementioned, there are also several limitations of the research which should be
discussed. First, the sample size was low, and did not meet best practice guidelines (N=200) per
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Kline.39 Having a limited and predetermined sample size reduced the power in our path models
to find significance. In order to address this, continued enrollment and increasing sample size
above 200 individuals would strengthen the statistical power and the findings. The second
limitation was the inability to obtain fit indices, which reduced the ability to compare models on
fit between each other. In the future, additional parameters should be added to create an
unsaturated model, which would provide us with the standard fit indices (e.g., CFI, GFI) to
compare our models to the index standards and to one another in determining the best model to
fit our data.53 Third, given the Reflective-Impulsive Model framework applied, the current data
does not include indicators or the recommended measurement types for all of the model
components. Therefore, adding measures that capture all components of the theory could
strengthen the model.13,14 Fourth, our findings may not generalize to all youth living with HIV in
that our sample was predominately African American and living in the South. The Southern U.S.
is unique in the disproportion of HIV infections and limited resources for support compared to
more metropolitan settings, which could play a role in medication access and adherence.1 Lastly,
our research relied predominately on self-report, which can be subject to social desirability and
biases related to self-judgment. Incorporation of more objective measures (e.g., electronic
monitors of adherence), could increase our information to better aggregate the data to more
accurately predict behaviors.
Future Directions
The present study provides limited insight into health and risk factors related to
adherence to ART in youth living with HIV, but may offer some suggestions for future research.
Other researchers working on similar aims have found that a variety of factors including but not
limited to negative affect, substance use, younger age, physical activity, and regimen
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simplification, contribute to nonadherence of ART.3,41,54 Based on the majority of the literature,
increased efforts are needed to identify predictors that maintain and/or increase adherence as
well as barriers to adherence. More specifically, researchers should continue their efforts to
expand targeted interventions aligned with the current “prevention of HIV by treatment of HIV”
to address adherence while also preventing the spread of HIV.
Future studies would benefit from a sample size larger than 200 individuals, and from an
a priori approach in which all of the components of the Reflective-Impulsive Model (RIM) are
measured. For instance, adding cognitive components such as an individual’s cognitive ability,
cognitive load, and self-control would add components that have been identified as important to
include in the model.16,26 The use of implicit tests to measure impulsive precursors is also
warranted. An experimental design involving both self-report and the Implicit Association Task
could shed light on how risk behaviors are best measured to predict ART adherence in youth
living with HIV.
It would also be advantageous for future research to expand the range of items and scales
collected for each predictor and indicator. Specifically, inclusion of Likert-type items involving
multiple risk (e.g., unprotected sex, substance use) and health promoting behaviors (e.g.,
physical activity, nutritional eating) would address the restricted range and likely generate more
item variance. In doing this, we would capture a broader range of behaviors that represent the
constructs of “risk” and “health promotion,” which would also lead to more accurate
measurements within the model and improved validity and reliability. Research examining youth
living with HIV should also examine within group differences by utilizing measures that account
for important individual differences. For instance, it would be important to differentiate types of
ART regimen (e.g., 1 pill versus 2 pills or multiple administrations a day), which is known to
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uniquely predict adherence.41 Another influential, and emphasized, construct in the ART
adherence literature is an individual’s experience of stigma and life and social stressors.43,55
Measurement of these commonly-related constructs could provide us with more information
about the psychological process of youth living with HIV, and insight into the best predictors of
their adherence.
Lastly, a logical expansion of this project would also be to include a personality measure
to capture conscientiousness, defined as the propensity to follow socially prescribed norms for
impulse control, to be goal directed, to plan, and to be able to delay gratification. 56 Inclusion of
this construct would add the measurement of a possibly important individual difference in youth
living with HIV. These results could help researchers further understand characteristics of their
sample, while drawing on a potentially independent and unique predictor of ART adherence
related to multiple variables in the current study (reflective cognitions, health promotion
behaviors, and inversely with risk behaviors). For example, one meta-analysis found small to
medium effect sizes in the majority of studies investigating individuals who were high in
conscientiousness related to physical activity (rb = -.03 to .42), unhealthy eating (rb = -.03 to .37), excessive alcohol use (rb = -.07 to -.69), and substance use (rb = -.06 to .60). These
highlight the role conscientiousness could play if added to the current models. 26,57
Clinical Implications
Given the lack of significant findings and the limitation of the study, there is little that
can be said about clinical implication from our findings. Since the participants in this sample
came from a hard to study sample of young individuals engaged in treatment, our findings
suggest that it will be important to do a more comprehensive clinical interview when evaluating
this groups ART adherence. Also these results, and current literature, strongly indicate that
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healthcare providers in the Southern U.S. may also face more barriers to facilitating health
promotion behaviors.

Conclusion
After testing our hypothesized models, it was found that risk behaviors, health promotion
behaviors, and depressive symptoms did not appear to be significant predictors of three ART
adherence indicators (self-reported VAS, self-reported last missed dosage, and pharmacy pill
count) in this sample. Additionally, depressive symptoms did not appear to mediate the
relationship between our predictor variables (risk and health promotion behaviors) and the ART
adherence indicators. One plausible explanation for these findings is that we were not able to
identify or measure sufficient predictors in our model that could have accounted for significant
variance in predicting the ART adherence. For instance, in the past researchers have used
cognitive processes, social support, and experience of stigma as predictors of ART
adherence.12,41,55 Researchers should further examine a broader range of risk and health
promoting behaviors and cognitive processes and how these interact within a decision-making
model. In addition, because our sample was predominately gay, MSM, horizonally horizontallyinfected youth living in the Southern U.S., perhaps other variables could have been explored
within the hypothesized model. For instance, measuring types of stigma (self, perceived, and
enacted), disclosure of status to social support (friends, family, and spiritual leaders) could
potentially serve as constructs that identify community-defined values and mediate or moderate
transactions occurring within models of ART adherence. This would provide us with a
developmental and community-specific model and more insight into youth living with HIV and
their decision-making regarding ART adherence.

38

References
1.

2.
3.
4.

5.

6.
7.

8.
9.

10.

11.
12.

13.
14.
15.

16.
17.

18.

19.

Center for Disease Center (CDC). HIV Surveillance Report, 2014; vol. 26.
http://www.cdc.gov/hiv/library/reports/surveillance/. Published November 2015. Accessed March
2, 2017.: Centers for Disease Control and Prevention (CDC);2014.
Comulada WS, Swendeman DT, Rotheram-Borus MJ, Mattes KM, Weiss RE. Use of HAART
among young people living with HIV. American journal of health behavior. 2003;27, 389-400.
Hosek SG, Harper GW, Domanico R. Predictors of medication adherence among HIV-infected
youth. Psychology, health & medicine. 2005;10, 166-179.
Reisner MSL, Mimiaga MJ, Skeer MM, Perkovich MB, Johnson MCV, Safren SA. A review of
HIV antiretroviral adherence and intervention studies among HIV–infected youth. Topics in HIV
medicine: a publication of the International AIDS Society, USA. 2009;17, 14-27.
House. TW. National HIV/AIDS Strategy for theUnited States: Updated to 2020. Available at:
www.aids.gov/federal-resources/national-hiv-aids-strategy/nhas-update.pdf (Last accessed March
3, 2017).
Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated
HIV-positive individuals in the United States and Canada. PloS one. 2013;8(12):e81355.
Cohen MS, Smith MK, Muessig KE, Hallett TB, Powers KA, Kashuba AD. Antiretroviral
treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? The Lancet.
2013;382, 1515-1524.
Friedman SR, Cooper HL, Osborne AH. Structural and social contexts of HIV risk among
African Americans. American journal of public health. 2009; 99,1002-1008.
Remien RH, Exner TM, Morin SF, et al. Medication adherence and sexual risk behavior among
HIV-infected adults: implications for transmission of resistant virus. AIDS and Behavior.
2007;11, 663-675.
MacDonell K, Naar-King S, Huszti H, Belzer M. Barriers to medication adherence in
behaviorally and perinatally infected youth living with HIV. AIDS and Behavior. 2013;17(1):8693.
Jaggers JR. Clinical Exercise, Stress, and Hiv Infection: Identifying the Associations and Testing
theEffects. 2010.
Blashill AJ, Mayer KH, Crane H, et al. Physical activity and health outcomes among HIVinfected men who have sex with men: a longitudinal mediational analysis. Annals of Behavioral
Medicine. 2013;46(2):149-156.
Strack F, Deutsch R. Reflective and impulsive determinants of social behavior. Personality and
social psychology review. 2004;8(3):220-247.
Deutsch R, Strack F. Duality models in social psychology: From dual processes to interacting
systems. Psychological Inquiry. 2006;17(3):166-172.
Cheval B, Sarrazin P, Isoard-Gautheur S, Radel R, Friese M. Reflective and impulsive processes
explain (in) effectiveness of messages promoting physical activity: A randomized controlled trial.
Health Psychology. 2015;34(1):10.
Hofmann W, Friese M, Strack F. Impulse and self-control from a dual-systems perspective.
Perspectives on Psychological Science. 2009;4(2):162-176.
Friese M, Hofmann W, Wänke M. When impulses take over: Moderated predictive validity of
explicit and implicit attitude measures in predicting food choice and consumption behaviour.
British Journal of Social Psychology. 2008;47(3):397-419.
Duncan A, VanDevanter N, Ahmed R, Burrell-Piggott T, Furr-Holden CD. The role of substance
use in adherence to HIV medication and medical appointments. The Journal of the Association of
Nurses in AIDS Care: JANAC. 2014;25(3):262.
Tanney MR, Naar-King S, Murphy DA, Parsons JT, Janisse H. Multiple risk behaviors among
youth living with human immunodeficiency virus in five US cities. Journal of Adolescent Health.
2010;46(1):11-16.
39

20.

21.
22.

23.
24.

25.
26.
27.
28.

29.
30.
31.
32.

33.
34.

35.

36.

37.
38.
39.
40.

Carrico AW, Johnson MO, Morin SF, et al. Stimulant use is associated with immune activation
and depleted tryptophan among HIV-positive persons on anti-retroviral therapy. Brain, behavior,
and immunity. 2008;22(8):1257-1262.
Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA. Cannabis use and HIV antiretroviral
therapy adherence and HIV-related symptoms. Journal of behavioral medicine. 2014;37(1):1-10.
Chandwani S, Abramowitz S, Koenig LJ, Barnes W, D'Angelo L. A multimodal behavioral
intervention to impact adherence and risk behavior among perinatally and behaviorally HIVinfected youth: description, delivery, and receptivity of adolescent impact. AIDS Education and
Prevention. 2011;23(3):222-235.
Eller LS, Corless I, Bunch EH, et al. Self‐care strategies for depressive symptoms in people with
HIV disease. Journal of Advanced Nursing. 2005;51(2):119-130.
Murphy DA, Durako SJ, Moscicki A-B, et al. No change in health risk behaviors over time
among HIV infected adolescents in care: role of psychological distress. Journal of adolescent
Health. 2001;29(3):57-63.
Murphy DA, Wilson C, Durako S, Muenz L, Belzer M. Antiretroviral medication adherence
among the REACH HIV-infected adolescent cohort in the USA. AIDS care. 2001;13(1):27-40.
Hofmann W, Friese M, Wiers RW. Impulsive versus reflective influences on health behavior: A
theoretical framework and empirical review. Health Psychology Review. 2008;2(2):111-137.
Wilkins ML, Dallas RH, Porter JS, et al. Characterizing body image in youth with HIV. AIDS
and Behavior. 2016;20(8):1585-1590.
Brener ND, Kann L, Shanklin S, et al. Methodology of the youth risk behavior surveillance
system—2013. Morbidity and Mortality Weekly Report: Recommendations and Reports.
2013;62(1):1-20.
McHugh ML. Interrater reliability: the kappa statistic. Biochemia medica: Biochemia medica.
2012;22(3):276-282.
Brener ND, Kann L, McManus T, Kinchen SA, Sundberg EC, Ross JG. Reliability of the 1999
youth risk behavior survey questionnaire. Journal of adolescent health. 2002;31(4):336-342.
Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older
adults: evaluation of. Prev Med. 1994;10:77-84.
Mohebbi M, Nguyen V, McNeil JJ, et al. Psychometric properties of a short form of the Center
for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in
healthy community dwelling older adults. General hospital psychiatry. 2017.
Zhang W, O’Brien N, Forrest JI, et al. Validating a shortened depression scale (10 item CES-D)
among HIV-positive people in British Columbia, Canada. PloS one. 2012;7(7):e40793.
Amico KR, Fisher WA, Cornman DH, et al. Visual analog scale of ART adherence: association
with 3-day self-report and adherence barriers. JAIDS Journal of Acquired Immune Deficiency
Syndromes. 2006;42(4):455-459.
Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to
antiretroviral therapy in a diverse population using a visual analogue scale. HIV clinical trials.
2004;5(2):74-79.
Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to
antiretroviral therapy are consistent with electronic data and virological treatment outcome. Aids.
2002;16(2):269-277.
Williams AB, Amico KR, Bova C, Womack JA. A proposal for quality standards for measuring
medication adherence in research. AIDS and Behavior. 2013;17(1):284-297.
Lam WY, Fresco P. Medication adherence measures: an overview. BioMed Research
International. 2015;2015.
Kline R. Principles and Practice of Structural Equation Modeling, 3rd edn Guilford Press. New
York. 2011.
Kenny DA, Kaniskan B, McCoach DB. The performance of RMSEA in models with small
degrees of freedom. Sociological Methods & Research. 2015;44(3):486-507.
40

41.

42.

43.
44.

45.

46.
47.
48.

49.

50.

51.
52.

53.
54.
55.
56.
57.

Glass TR, Battegay M, Cavassini M, et al. Longitudinal analysis of patterns and predictors of
changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study. JAIDS
Journal of Acquired Immune Deficiency Syndromes. 2010;54(2):197-203.
Kalichman SC. HIV transmission risk behaviors of men and women living with HIV‐AIDS:
Prevalence, predictors, and emerging clinical interventions. Clinical Psychology: Science and
Practice. 2000;7(1):32-47.
Rao D, Feldman BJ, Fredericksen RJ, et al. A structural equation model of HIV-related stigma,
depressive symptoms, and medication adherence. AIDS and Behavior. 2012;16(3):711-716.
Wang B, Li X, Barnett D, Zhao G, Zhao J, Stanton B. Risk and protective factors for depression
symptoms among children affected by HIV/AIDS in rural China: A structural equation modeling
analysis. Social Science & Medicine. 2012;74(9):1435-1443.
Greenwald AG, McGhee DE, Schwartz JL. Measuring individual differences in implicit
cognition: the implicit association test. Journal of personality and social psychology.
1998;74(6):1464.
Payne BK, Cheng CM, Govorun O, Stewart BD. An inkblot for attitudes: affect misattribution as
implicit measurement. Journal of personality and social psychology. 2005;89(3):277.
Baskin ML, Ard J, Franklin F, Allison DB. Prevalence of obesity in the United States. Obesity
reviews. 2005;6(1):5-7.
Belcher BR, Berrigan D, Dodd KW, Emken BA, Chou C-P, Spuijt-Metz D. Physical activity in
US youth: Impact of race/ethnicity, age, gender, & weight status. Medicine and science in sports
and exercise. 2010;42(12):2211.
Kupek E. Beyond logistic regression: structural equations modelling for binary variables and its
application to investigating unobserved confounders. BMC medical research methodology.
2006;6(1):13.
Fulkerson JA, Sherwood NE, Perry CL, Neumark-Sztainer D, Story M. Depressive symptoms
and adolescent eating and health behaviors: a multifaceted view in a population-based sample.
Preventive medicine. 2004;38(6):865-875.
Allgöwer A, Wardle J, Steptoe A. Depressive symptoms, social support, and personal health
behaviors in young men and women. Health Psychology. 2001;20(3):223.
Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment
nonadherence: a review and meta-analysis. Journal of acquired immune deficiency syndromes
(1999). 2011;58(2).
McDonald RP, Ho M-HR. Principles and practice in reporting structural equation analyses.
Psychological methods. 2002;7(1):64.
Atkinson MJ, Petrozzino JJ. An evidence-based review of treatment-related determinants of
patients' nonadherence to HIV medications. AIDS patient care and STDs. 2009;23(11):903-914.
Tanney MR, Naar-King S, MacDonnel K. Depression and stigma in high-risk youth living with
HIV: a multi-site study. Journal of Pediatric Health Care. 2012;26(4):300-305.
MacCann C, Duckworth AL, Roberts RD. Empirical identification of the major facets of
conscientiousness. Learning and Individual Differences. 2009;19(4):451-458.
Bogg T, Roberts BW. Conscientiousness and health-related behaviors: a meta-analysis of the
leading behavioral contributors to mortality. Psychological bulletin. 2004;130(6):887.

41

